BioSpace News Archive

Axonics Modulation Technologies, Inc. announced the publication of the 1-year results from its ARTISAN-SNM study in the peer-reviewed journal Neurourology & Urodynamics https://doi.org/10.1002/nau.24376.

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (“CBN”), today announced the filing of a key Patent Cooperatio

Data-Driven Dashboard Provides Health Plans, Employers, and Government Agencies with Expanded Insight into COVID-19 Incidence and Relative Risk within Definable Populations

Science 37, the industry leader in virtual clinical trials, announced today that Mike Zaranek has joined the company as its chief financial officer (CFO). He will oversee all aspects of finance, accounting, and

Tricida, Inc. (Nasdaq: TCDA) today announced that it intends to offer $175.0 million aggregate principal amount of its Convertible Senior Notes due 2027 (the “Notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering, Tricida expects to grant the initial purchasers a

Clinical trial led by CHOP researchers found the primary care-based intervention led to less distress among teens and more positive feelings

Highly experienced physician with an excellent track record in clinical development at early stage biotech and big pharma